CAM
REGN icon

Centre Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Centre Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$7.74M Buy
+12,203
New +$8.39M 1.99% 25
2019
Q1 		– Sell
-21,890
Closed -$8.18M – 69
2018
Q4 		$8.18M Sell
21,890
-660
-3% -$242K 2.41% 14
2018
Q3 		$9.11M Sell
22,550
-880
-4% -$335K 2.12% 12
2018
Q2 		$8.08M Buy
+23,430
New +$7.33M 1.9% 17

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Centre Asset Management's REGN Position: Q1 2025 in Review

Centre Asset Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2025: 12,203 shares worth $7.74M. The stake represents 1.99% of the portfolio and ranks #25 among its holdings. This is a return to the name: Centre Asset Management previously reported a position in REGN as recently as Q4 2018.

Centre Asset Management first reported a position in REGN in Q2 2018 and has held it in 4 quarters since. The position peaked at $9.11M in Q3 2018. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • Centre Asset Management held 12,203 shares of Regeneron Pharmaceuticals worth $7.74M as of Q1 2025.
  • Regeneron Pharmaceuticals was a new Centre Asset Management position in Q1 2025.
  • Regeneron Pharmaceuticals made up 1.99% of Centre Asset Management's portfolio in Q1 2025, its #25 holding.
  • Centre Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2018 and has held it in 4 quarters since.
  • Centre Asset Management's Regeneron Pharmaceuticals position peaked at $9.11M in Q3 2018.
  • 1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on Centre Asset Management's 13F filing for Q1 2025, filed 1 Apr 2025.